ArticleBMC geriatrics2026

Tislelizumab-induced lichenoid drug eruption and cutaneous squamous cell carcinoma: a rare dermatologic immune-related adverse event.

Xiang ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.